Testing a new hair loss treatment for women with female pattern baldness
Part of Skin clinical trials.
This study tests a new medication (N1087) for female pattern hair loss in women aged 18 to 60. It aims to see if the treatment helps regrow hair and is safe.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 18 and 60 years old.
- You have female pattern hair loss (thinning on top of the scalp) that is mild to moderate, as rated by a doctor using a special scale.
- You have not used any specific hair loss treatments in the last 6 months, or if you have, it was for less than 30 days. If you have used them longer, you must stop for 3 months before joining.
- You agree to get a small permanent tattoo on your scalp and have a small area of your head shaved for the study.
- You are willing to keep your hair style, length, and color the same, and use the same hair products throughout the study.
- You do not have other causes of hair loss, like patchy bald spots, scarring, or hair loss from stress, childbirth, or illness.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new treatment (DA-001) to reduce hair shedding and help hair grow back in people with telogen effluvium—a temporary hair loss condition. The treatment is applied directly to the scalp, and participants will be followed to see how well it works.
This Phase 3 trial studies whether OMA102 helps women with female pattern hair loss and checks its safety. You might be eligible if you have the right age and hair-loss pattern and can follow study rules about hair and other treatments.
This trial tests a new treatment for male pattern baldness (androgenic alopecia). It is for men with a moderate level of hair loss who have not used any hair loss treatments in the last 90 days.
This trial tests a new medication called ABS-201 for hair loss. It will first see if the medicine is safe in healthy people, then test if it helps those with male or female pattern baldness.
This study tests two new topical treatments (DA-002 and DA-005) for hair loss in people with pattern baldness. The goal is to see if they can help hair grow back.
This study tests an experimental treatment called EPI-001 for androgenetic alopecia—the most common type of hair loss affecting men and women. Researchers will measure how well it works by tracking hair growth over time using special photography and scalp analysis.
Hear when a new Female Pattern Hair Loss trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.